DanCann Pharma A/S strengthens the Board of Directors with experienced investment profile Tue Østergaard
COPENHAGEN, Denmark, 2 May 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that Tue Østergaard, CEO of HC Andersen Capital, was elected to the Company's Board of Directors.At DanCann Pharma's Annual General Meeting on Wednesday 27 April 2022, Tue Østergaard, CEO of HC Andersen Capital, was elected to the Company's Board of Directors. In connection with the election to the Board of Directors, Carsten Trads was able to welcome Tue Østergaard. The experienced investment profile, who is CEO of the fast-